Request Sample Report

View Synopsis & Table of Content
{reportSlug=global-radiopharmaceuticals-in-nuclear-medicine-market, reportId=50239, mktKeyword=Radiopharmaceuticals in Nuclear Medicine, cagr=0.00, publishDate=Nov 2021, priceOption2=7500, reportTitle=Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters), Brachytherapy Isotopes (Iodine-125, Palladium-103, Cesium-131, Iridium-192, Other)), Application (SPECT Applications (Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications), PET Applications (Oncology, Cardiology, Neurology, Other PET Applications), Therapeutic Applications (Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other)), End User (Hospitals, Research Institutes, Others) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=200, priceOption1=3750, forecastYr=2027, noOfPages=208, reportKey=49933, breadcrum=Global Radiopharmaceuticals in Nuclear Medicine}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Nov 2021 208 Pages 81 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner